Clarivate
Provides data, analytics, workflow tools, and expert services for research and intellectual-property customers.
Something off on this page? Send us feedback.
Profile
Sells data, analytics, workflow solutions, and expert services to academia, government, and intellectual-property customers. Its portfolio was built through a carve-out and acquisitions, while the agreed sale of Life Sciences & Healthcare would concentrate it on the other two markets.
Data, analytics, workflow solutions, and expert services support Academia & Government, Intellectual Property, and Life Sciences & Healthcare. The portfolio includes inherited brands such as Web of Science, Cortellis, Derwent, CompuMark, MarkMonitor, and Techstreet, while ProQuest broadened the academic software, content, data, and analytics offering.
Created from Thomson Reuters’ Intellectual Property & Science business, the business expanded through acquisitions including Decision Resources Group, CPA Global, and ProQuest. Its public-market route was a merger with Churchill Capital Corp rather than a conventional operating-company IPO. A July 2026 agreement to sell Life Sciences & Healthcare is intended to focus operations on Academia & Government and Intellectual Property, subject to closing conditions.
Company facts
Key statistics
Year to date −37.5% · Average volume (30d) 5.1M
Analysts
Ratings
Target range
Latest analyst notes
| Date | Firm | Action | Prior rating | Rating | Prior target | Target |
|---|---|---|---|---|---|---|
| Jul 30, 2026 | Barclays | Reiterate | Underweight | $2.50 | $2 | |
| Jul 7, 2026 | Barclays | Reiterate | Underweight | $2.50 | ||
| Jan 8, 2026 | Goldman Sachs | Downgrade | Buy | Neutral | $4.20 | $3.60 |
| Dec 17, 2025 | Morgan Stanley | Downgrade | Equal Weight | Underweight | $12 | $3 |
| Oct 30, 2025 | Goldman Sachs | Target | $20 | $4.20 |
Earnings
EPS
Revenue
History
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Next session |
|---|---|---|---|---|---|---|---|
| Jul 29, 2026Q2 FY26 | $0.18 | $0.19 | +4.6% | $589.7M | $587.3M | −0.4% | −10.42% |
| Apr 29, 2026Q1 FY26 | $0.14 | $0.18 | +28.6% | $569.5M | $585.5M | +2.8% | +0.35% |
| Feb 24, 2026Q4 FY25 | $0.16 | $0.20 | +25.0% | $604.8M | $617.0M | +2.0% | −2.13% |
| Oct 29, 2025Q3 FY25 | $0.16 | $0.18 | +12.5% | $604.8M | $623.1M | +3.0% | −7.16% |
Financial highlights
| 12 quarters | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | |
|---|---|---|---|---|---|---|---|
| Revenue | $593.7M | $621.4M | $623.1M | $617.0M | $585.5M | $587.3M | |
| Gross profit | $386.7M | $417.8M | $404.9M | $412.2M | $393.4M | $401.8M | |
| Operating income | −$20.8M | $6.9M | $44.0M | $41.4M | $30.2M | −$200.2M | |
| Net income | −$103.9M | −$72.0M | −$28.3M | $3.1M | −$40.2M | −$268.6M | |
| Diluted EPS | −$0.15 | −$0.11 | −$0.04 | $0.00 | −$0.06 | −$0.42 | |
| Gross margin | 65.1% | 67.2% | 65.0% | 66.8% | 67.2% | 68.4% | |
| Operating margin | -3.5% | 1.1% | 7.1% | 6.7% | 5.2% | -34.1% |
Fiscal years (4-quarter sums)FY21 $1.88B · FY22 $2.66B · FY23 $2.63B · FY24 $2.56B · FY25 $2.46B
Revenue by product · Q2 FY26
Revenue by geography · FY25
Balance sheet, Jun 30, 2026Cash & short-term investments $217.7M · Total debt $4.26B · Total assets $10.49B · Shareholders' equity $4.54B
Dividends
No dividends on record.
Ownership
Shares outstanding 639.66M · Float 334.75M · 52.3% free float
Top shareholders13F · 13D/G · Form 4
| Holder | Shares | % outstanding | Form | Filed |
|---|---|---|---|---|
| Leonard Green & Partners, L.P. | 116.67M | 18.24% | 13F | Aug 14, 2026 |
| Exor N.V. | 67.29M | 10.52% | 13F | Aug 3, 2026 |
| Clarkston Capital Partners, LLC | 45.73M | 7.15% | 13F | Aug 11, 2026 |
| Seth A. Klarman | 38.93M | 5.38% | 13G | Nov 13, 2024 |
| BlackRock, Inc. | 31.15M | 4.87% | 13F | Aug 7, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Aug 7, 2026 | Kenneth L. Cornick | director | +250,000 | $1.85 |
| Aug 6, 2026 | Kenneth L. Cornick | director | +650,000 | $1.86 |
| Aug 3, 2026 | Andrew Miles Snyder | director | −2,489,618 | $1.94 |
| Dec 1, 2025 | Bar Veinstein | officer: President, A&G | −309,902 | $3.74 |
| Nov 10, 2025 | Kenneth L. Cornick | director | +100,000 | $3.45 |
Peers
- RELX (ADR)
Scientific research analytics and patent-search overlap
- Wiley Class A
Research publishing and digital research solutions overlap
CompareAfter-hours close
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Clarivate | $2.02 | −0.25% | $1.29B | — | 2.8 | 0.5 | −5.5% |
| RELX (ADR) | $36.54 | 0.00% | $63.79B | 21.3 | — | 4.8 | +0.4% |
| Wiley Class A | $53.71 | +0.03% | $2.82B | 12.9 | 11.2 | 1.7 | +1.2% |
| Median | 17.1 | 11.2 | 3.2 | +0.8% |




